The Pharmacovigilance And Drug Safety Software Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Pharmacovigilance And Drug Safety Software Market?
The market size for pharmacovigilance and drug safety software has experienced substantial growth over the years. It is projected to increase from $2.26 billion in 2024 to $2.55 billion in 2025 with a Compound Annual Growth Rate (CAGR) standing at 13.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Pharmacovigilance And Drug Safety Software Industry?
The 2029 market predictions for the Pharmacovigilance And Drug Safety Software Global Market Report 2025 suggest a market size of $4.15 billion, with a compound annual growth rate (CAGR) of 12.9%.
Download Your Free Sample of the 2025 Pharmacovigilance And Drug Safety Software Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Pharmacovigilance And Drug Safety Software Market?
The key drivers in the pharmacovigilance and drug safety software market are:
• Rising incidences of adverse drug reactions and increased globalization of pharmacovigilance
• Increased complexity in drug safety regulations
• Development of new drugs and therapies
• Advancements in technology, such as automation, AI integration, cloud solutions, and digitalization in healthcare.
Global Market Segmentation: Identifying Major Pharmacovigilance And Drug Safety Software Industry Segments
The pharmacovigilance and drug safety softwaremarket covered in this report is segmented –
1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software
2) By Delivery Mode: On-premise, Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users
Pre-order the 2025 Pharmacovigilance And Drug Safety Software Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Pharmacovigilance And Drug Safety Software Market?
The key trends in the pharmacovigilance and drug safety software market are:
• Automation and AI integration are emerging as important trends in the pharmacovigilance and drug safety software market.
• The market is seeing a shift towards cloud-based solutions.
• Technological innovation is greatly impacting the future of the market.
• The increasing digitalization of healthcare is an emerging trend shaping the industry.
Who Are the Top Competitors & Leading Players in the Pharmacovigilance And Drug Safety Software Market?
Major companies in the pharmacovigilance and drug safety software market are:
• Accenture plc
• International Business Machines Corporation
• Deloitte Touche Tohmatsu Limited
• Oracle Corporation
• Capgemini SE
• Cognizant Technology Solutions
• IQVIA
• Wipro Limited
• Genepact
• Parexel Academy
• PharmaLex
• Indegene Limited
• RXLogix
• Sarjen Systems Pvt Ltd.
• Anju Software Inc.
• Ennov Group
• EXTEDO GmbH
• ArisGlobal
• AB Cube
• Clinevo Technologies
Regional Dominance: Which Area Leads the Global Pharmacovigilance And Drug Safety Software Market?
North America was the largest region in the pharmacovigilance and drug safety software market in 2024
